ICMI 2015

W.107 Gut Microbiota Composition Imprints Optimal Humoral Immunity

Wednesday, July 15, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Hazel Poyntz , Malaghan Institute of Medical Research, Wellington, WGN, New Zealand
Marcus Robinson , Malaghan Institute of Medical Research, Wellington, New Zealand
Lucas Pitt , Malaghan Institute of Medical Research, Wellington, New Zealand
Charlotte Everitt , Malaghan Institute of Medical Research, Wellington, New Zealand
Catherine Plunkett , Malaghan Institute of Medical Research, Wellington, New Zealand
Lieke van den Elsen , Malaghan Institute of Medical Research, Wellington, New Zealand
Angela Jones , Malaghan Institute of Medical Research, Wellington, New Zealand
Karmella Naidoo , Malaghan Institute of Medical Research, Wellington, New Zealand
Jessica Jones , Malaghan Institute of Medical Research, Wellington, New Zealand
Markus Geuking, PhD , Division of Gastroenterology, Department of Clinical Research, University Clinic for Visceral Surgery and Medicine, University of Bern, 3010 Bern, Switzerland
Kathy McCoy , University of Bern, Bern, Switzerland
Graham Le Gros, Prof , Malaghan Institute of Medical Research, Wellington, New Zealand
Elizabeth Forbes-Blom, PhD , Malaghan Institute of Medical Research, Wellington, New Zealand
The infant immune system co-evolves with the developing gut microbiota in a mutualistic relationship, providing signals that imprint immune health for life. Recent studies have demonstrated the immunomodulatory effects microbiota exert on humoral immune development using germ-free mice and antibiotic treatment. However, examining the impact that naturally divergent gut microbial communities have on the development of humoral immunity remains to be elucidated.

We have developed a model system whereby two lines of BALB/c mice harbour naturally divergent gut microbiota, resulting in a prominent difference in the Firmicutes to Bacteroidetes ratio. These two lines of mice demonstrate disparate levels of immune activation, resulting in markedly different antibody responses. In turn, protective immunity to infectious disease and susceptibility to allergic disease is affected. Microbiota transfer in early life is able to alter the antibody phenotype in both lines of BALB/c mice; demonstrating microbial composition imprints the capability of the humoral response throughout life. Taken together, we have established a critical window during the ontogeny of the immune system in which gut microbial composition may be therapeutically manipulated to promote optimal humoral immunity.